A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2002
10/24/2002	US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/24/2002	US20020155430 Lentiviral vector system for high quantity screening
10/24/2002	US20020155157 Compositions and methods for polynucleotide delivery
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155127 Genetic vaccine against human immunodeficiency virus
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	US20020155104 Altering T cell mediated immunity comprising altering local extracellular concentrations of tryptophan and tryptophan metabolites
10/24/2002	US20020155101 Cardiac arrhythmia treatment methods
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	US20020155095 Introducing into tissue of interest recombinant vector comprising nucleic acid segment encoding interferon alpha polypeptide, nucleic acid segment being operatively linked to a promoter having specificity for tissue of interest
10/24/2002	US20020155084 Nanoemulsion formulations
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	DE10118405A1 Heterostructure component used in electronic devices comprises a single hetero-nanotube having regions made from nanotube materials having different energy band gaps value
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444840A1 Akt and regulation of ra synovial fibroblast apoptosis
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444421A1 Modification of the sustained release profile
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444048A1 Novel immunogenic compositions comprising modified and unmodified antigens
10/24/2002	CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity
10/24/2002	CA2444001A1 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
10/24/2002	CA2443968A1 Diagnosis and treatment of cancer: i
10/24/2002	CA2443923A1 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002	CA2443732A1 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	CA2442670A1 Method of treating or retarding the development of blindness
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/23/2002	EP1251174A1 Use of paramyxovirus vector in gene transfer into blood vessel
10/23/2002	EP1251171A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality
10/23/2002	EP1250457A2 Cancer associated genes and their products
10/23/2002	EP1250455A1 Antisense inhibition of ptp1b expression
10/23/2002	EP1250446A1 Replication competent herpes virus strains
10/23/2002	EP1250438A2 Therapeutic polypeptides and methods for using same
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250430A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250421A1 Recombinant flaviviruses and methods of use thereof
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250349A2 Cardiac-cell specific enhancer elements and uses thereof
10/23/2002	EP1250348A1 Antisense modulation of daxx expression
10/23/2002	EP1250157A1 Antisense modulation of inducible nitric oxide synthase expression
10/23/2002	EP1250156A1 Method for nucleic acid transfection of cells
10/23/2002	EP1250155A1 Angiogenesis and vascular permeability modulators and inhibitors
10/23/2002	EP1250152A1 Hyaluronic acid in the treatment of cancer
10/23/2002	EP1250149A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer
10/23/2002	EP1144009B1 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/23/2002	EP1063891A4 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/23/2002	EP0880594B1 Retroviral vector and its use in gene therapy
10/23/2002	EP0771362B1 Genetic diagnosis and pharmaceutical compositions for treatment of prostate cancer
10/23/2002	CN1376200A DNA vaccine-PCV
10/23/2002	CN1376197A Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
10/23/2002	CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002	CN1376056A Liposome-entrapped DNA oral vaccines
10/23/2002	CN1375335A Beta signal transduction blocker as a transforming growth factor and its use
10/23/2002	CN1375334A New-type in vivo nucleic acid transfection reagent
10/22/2002	US6469158 Synthesis, deprotection, analysis and purification of RNA and ribozymes
10/22/2002	US6469152 Flea allantoinase nucleic acid molecules, proteins and uses thereof
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002	US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth
10/22/2002	US6468982 Orally administering composition comprising bupivacaine and dna molecules comprising dna sequence encoding antigen linked to regulatory sequences which control expression; cellsexpressing sequence generate immune response against
10/22/2002	US6468981 Compound comprising steroid moiety which binds to androgen receptor covalently linked to polycationic salt complexed with nucleic acid capable of therapeutically modifying or revealing presence of androgen receptor-containing cell
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002	US6468771 Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal DNA of target cells
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468547 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468527 Biological bioadhesive composition and methods of preparation and use
10/22/2002	US6468524 AAV4 vector and uses thereof
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081745A2 Genes involved in osteogenesis, and methods of use
10/17/2002	WO2002081726A2 Modulation of gene expression in mouse genetic models of atherosclerosis
10/17/2002	WO2002081716A1 Improved ovine adenovirus vector
10/17/2002	WO2002081712A2 Artificial chromosomes comprising ehv sequences
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081706A2 Regulation of human phosphatase-like protein
10/17/2002	WO2002081705A2 Regulation of human gnat acetyltransferase-like protein
10/17/2002	WO2002081704A2 Regulation of human protein kinase-like protein
10/17/2002	WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002	WO2002081689A1 Regulation of human cyclic nucleotide-gated channel ocnc2 subunit
10/17/2002	WO2002081687A2 Yeast genes that affect viral replication
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081674A1 Alpha-galactosidase as food-grade genetic marker
10/17/2002	WO2002081665A2 Implantation serine proteinases

1 ... 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 ... 870